We are live on
!
Find out more
YIH
Y-Intercept (HK) Portfolio holdings
AUM
$5.05B
1-Year Est. Return
17.89%
This Fund
S&P 500
This Quarter
Est. Return
+8.14%
1 Year Est. Return
+17.89%
3 Year Est. Return
+34.37%
5 Year Est. Return
+20.59%
10 Year Est. Return
–
AUM
$4.09B
AUM Growth
+$2.61B
(+177%)
Cap. Flow
+$2.46B
Cap. Flow
% of AUM
60.1%
Top 10 Holdings %
Top 10 Hldgs %
6.33%
Holding
2,105
New
963
Increased
487
Reduced
137
Closed
518
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$37.8M |
| 2 |
Sarepta Therapeutics
SRPT
|
+$35.1M |
| 3 |
T-Mobile US
TMUS
|
+$30.4M |
| 4 |
Nu Holdings
NU
|
+$27.8M |
| 5 |
Consolidated Edison
ED
|
+$26.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Arista Networks
ANET
|
+$17M |
| 2 |
Marvell Technology
MRVL
|
+$16.2M |
| 3 |
NVO
Novo Nordisk
NVO
|
+$16.1M |
| 4 |
ServiceNow
NOW
|
+$13.3M |
| 5 |
Walmart Inc
WMT
|
+$10.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.87% |
| 2 | Industrials | 14.69% |
| 3 | Financials | 14.36% |
| 4 | Healthcare | 12.68% |
| 5 | Consumer Discretionary | 12.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
UHG
1576
DELISTED
United Homes Group
UHG
| $35.1K | ﹤0.01% |
+12,103
| New | +$31.5K |
|
1577
374Water
SCWO
$37.4M
| $34.6K | ﹤0.01% |
+10,671
| New | +$35.9K |
|
|
AKYA
1578
DELISTED
Akoya BioSciences
AKYA
| $34.4K | ﹤0.01% |
+26,464
| New | +$31.8K |
|
|
QIPT
1579
DELISTED
Quipt Home Medical
QIPT
| $33.9K | ﹤0.01% |
+18,949
| New | +$37.4K |
|
1580
Rekor Systems
REKR
$82.6M
| $32.9K | ﹤0.01% |
+28,396
| New | +$29.8K |
|
|
IRBT
1581
DELISTED
iRobot
IRBT
| $31.6K | ﹤0.01% |
+10,102
| New | +$27.9K |
|
1582
Leslie's
LESL
$8.33M
| $28.3K | ﹤0.01% |
+3,368
| New | +$44.3K |
|
1583
Offerpad Solutions
OPAD
$18.5M
| $16.2K | ﹤0.01% |
+1,775
| New | +$20.4K |
|
1584
Harvard Bioscience
HBIO
$27.6M
| $7.52K | ﹤0.01% |
+1,694
| New | +$7.08K |
|
1585
LanzaTech
LNZA
$59.9M
| $5.56K | ﹤0.01% |
+205
| New | +$5.03K |
|
|
ELEV
1586
DELISTED
Elevation Oncology
ELEV
| $5.14K | ﹤0.01% |
+14,016
| New | +$4.68K |
|
|
LNAI
1587
Lunai Bioworks
LNAI
$9.57M
| $4.19K | ﹤0.01% |
+181
| New | +$5.05K |
|
1588
Agilent Technologies
A
$39.6B
| – | – |
-40,018
| Closed | -$4.68M |
|
1589
AbbVie
ABBV
$465B
| – | – |
-9,251
| Closed | -$1.94M |
|
1590
Ameris Bancorp
ABCB
$5.89B
| – | – |
-16,752
| Closed | -$964K |
|
1591
Asbury Automotive
ABG
$4.62B
| – | – |
-4,420
| Closed | -$976K |
|
1592
Abbott
ABT
$188B
| – | – |
-1,850
| Closed | -$245K |
|
1593
Acadia Pharmaceuticals
ACAD
$4.51B
| – | – |
-14,527
| Closed | -$241K |
|
1594
Albertsons Companies
ACI
$5.91B
| – | – |
-97,565
| Closed | -$2.15M |
|
1595
American Coastal Insurance
ACIC
$536M
| – | – |
-15,531
| Closed | -$180K |
|
1596
Aecom
ACM
$9.46B
| – | – |
-10,147
| Closed | -$941K |
|
1597
Enact Holdings
ACT
$6.75B
| – | – |
-12,694
| Closed | -$441K |
|
1598
iShares MSCI ACWI ex US ETF
ACWX
$11.2B
| – | – |
-3,670
| Closed | -$204K |
|
1599
Analog Devices
ADI
$172B
| – | – |
-15,155
| Closed | -$3.06M |
|
1600
Adient
ADNT
$1.69B
| – | – |
-80,583
| Closed | -$1.04M |
|
Similar funds
HSA
O
LFG
JIM
CTC
NL
BPWM
VT
Y-Intercept (HK)'s Q2 2025 Portfolio in Review
As of Q2 2025, Y-Intercept (HK) held 2,105 positions worth $4.09B, up 177% from $1.48B the previous quarter. Its ten largest holdings account for 6.3% of the portfolio.
Y-Intercept (HK) deployed $2.46B of net new capital in Q2 2025, opening 963 new positions and adding to 487 existing holdings. Its largest new stake was Nu Holdings: 2,319,643 shares worth $31.8M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 19% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was Novo Nordisk, an estimated $16.1M trimmed.
- Y-Intercept (HK)'s largest Q2 2025 buy was Nu Holdings: 2,319,643 shares worth $31.8M.
- Y-Intercept (HK) added most to UnitedHealth in Q2 2025, an estimated $37.8M increase.
- Y-Intercept (HK)'s biggest Q2 2025 reduction was Novo Nordisk, cutting an estimated $16.1M.
- Y-Intercept (HK) fully exited Arista Networks in Q2 2025, selling an estimated $17M.
- Y-Intercept (HK)'s ten largest holdings make up 6.3% of its $4.09B portfolio in Q2 2025.
- Y-Intercept (HK) opened 963 new positions and closed 518 in Q2 2025.
- Y-Intercept (HK)'s portfolio value rose 177% quarter-over-quarter to $4.09B.
Based on Y-Intercept (HK)'s 13F filing for Q2 2025, filed 1 Aug 2025.